Vance Street Capital said it has acquired Injectech from The West Group and formed the VSC Medical Molding platform. The acquisition of Injectech expands VSC Medical Molding's single-use fluid management solutions offering in the medical device, life science and bioprocessing markets.
In addition to Injectech, the VSC Medical Molding platform is comprised of Plastic Design Company, which was acquired in 2021, and Resenex, which was acquired in 2024.
"By combining VSC Medical Molding's precision molding and in-house tooling capabilities with Injectech's extensive component portfolio of custom and standard fluid management solutions, we are expanding our ability to deliver specialized solutions for our customers across critical medical, life science and bioprocessing applications," said VSC Medical Molding CEO Jeff Kyle in a statement.
VSC Medical Molding's fluid management division will now be comprised of Injectech and Resenex, enabling the platform to meet a wider range of fluid management needs for its customers through a broader product and component portfolio as well as expanded custom component capabilities. The fluid management segment will continue to focus on serving the medical, life science and bioprocessing markets.
